Literature DB >> 27664332

Nasal drug absorption from powder formulations: The effect of three types of hydroxypropyl cellulose (HPC).

Akiko Tanaka1, Tomoyuki Furubayashi2, Manami Tomisaki1, Mayuko Kawakami1, Shunsuke Kimura3, Daisuke Inoue2, Kosuke Kusamori1, Hidemasa Katsumi1, Toshiyasu Sakane4, Akira Yamamoto1.   

Abstract

Despite the numerous advantages of powder formulations, few studies have described their nasal drug absorption. The first aim of this study was to compare the drug absorption from powder formulation with that from a liquid formulation in rats. Since pharmaceutical excipients are usually added to most powder formulations, the second aim of the study was to investigate the effect of hydroxypropyl cellulose (HPC) on nasal drug absorption from the powder. Three types of HPC with different polymerization degrees were used: HPC(SL), HPC(M), and HPC(H). The model drugs were warfarin (BCS Class I), piroxicam (BCS Class II), and sumatriptan (BCS Class III). The absorption of these model drugs in the powder form was higher than that from the solution. All HPCs failed to enhance warfarin absorption, while the piroxicam absorption was enhanced only by HPC(M). Sumatriptan absorption was not enhanced by HPC(SL), but by HPC(M) and HPC(H). The differences in nasal absorption of the three model drugs promoted by HPCs depend on the permeability and solubility of the drug. Moreover, the nasal retention of different formulations was increased by HPCs. Because HPCs showed no toxic effect on the nasal epithelium. These findings indicate that powder formulations supplemented with HPC are a valuable and promising approach to increase the nasal absorption of highly soluble and poorly permeable drugs.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Hydroxypropyl cellulose; Mucociliary clearance; Nasal drug absorption; Nasal residence; Powder formulation

Mesh:

Substances:

Year:  2016        PMID: 27664332     DOI: 10.1016/j.ejps.2016.09.028

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity.

Authors:  Rita Ambrus; Péter Gieszinger; Róbert Gáspár; Anita Sztojkov-Ivanov; Eszter Ducza; Árpád Márki; Tamás Janáky; Ferenc Tömösi; Gábor Kecskeméti; Piroska Szabó-Révész; Csilla Bartos
Journal:  Molecules       Date:  2020-02-27       Impact factor: 4.411

Review 2.  Recent Trends in Assessment of Cellulose Derivatives in Designing Novel and Nanoparticulate-Based Drug Delivery Systems for Improvement of Oral Health.

Authors:  Khaled M Hosny; Hala M Alkhalidi; Waleed S Alharbi; Shadab Md; Amal M Sindi; Sarah A Ali; Rana B Bakhaidar; Alshaimaa M Almehmady; Eman Alfayez; Mallesh Kurakula
Journal:  Polymers (Basel)       Date:  2021-12-27       Impact factor: 4.329

3.  A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies.

Authors:  Laura Nižić Nodilo; Ivo Ugrina; Drago Špoljarić; Daniela Amidžić Klarić; Cvijeta Jakobušić Brala; Mirna Perkušić; Ivan Pepić; Jasmina Lovrić; Vesna Saršon; Maša Safundžić Kučuk; Dijana Zadravec; Livije Kalogjera; Anita Hafner
Journal:  Pharmaceutics       Date:  2021-05-26       Impact factor: 6.321

4.  Preliminary study of nanonized lamotrigine containing products for nasal powder formulation.

Authors:  Péter Gieszinger; Ildikó Csóka; Edina Pallagi; Gábor Katona; Orsolya Jójárt-Laczkovich; Piroska Szabó-Révész; Rita Ambrus
Journal:  Drug Des Devel Ther       Date:  2017-08-23       Impact factor: 4.162

5.  In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates.

Authors:  Alessandro Giuliani; Anna Giulia Balducci; Elisa Zironi; Gaia Colombo; Fabrizio Bortolotti; Luca Lorenzini; Viola Galligioni; Giampiero Pagliuca; Alessandra Scagliarini; Laura Calzà; Fabio Sonvico
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

6.  Effects of Formulation and Process Variables on Gastroretentive Floating Tablets with A High-Dose Soluble Drug and Experimental Design Approach.

Authors:  Prakash Thapa; Seong Hoon Jeong
Journal:  Pharmaceutics       Date:  2018-09-17       Impact factor: 6.321

7.  Nasal Powder Formulations: In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects.

Authors:  Marie Trenkel; Regina Scherließ
Journal:  Pharmaceutics       Date:  2021-03-13       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.